Skip to Main Content
Table 1.

Nestin protein expression and prostate cancer stage

Total nNestin, detectable (%)Nestin, undetectable (%)
ADT-naive cases    
    Localized tumors 124 0 (0) 124 (100) 
    Metastatic lesions 46 0 (0) 46 (100) 
ADT-treated cases    
    Localized tumors 52 0 (0) 52 (100) 
Lethal metastatic cases (castration resistant)    
    Patients 32 24 (75) 8 (25) 
    Metastatic lesions 113 84 (74) 29 (26) 
    Primary tumors at autopsy 11 7 (64) 4 (36) 
    Preandrogen ablation tumor tissue* 0 (0) 4 (100) 
Total nNestin, detectable (%)Nestin, undetectable (%)
ADT-naive cases    
    Localized tumors 124 0 (0) 124 (100) 
    Metastatic lesions 46 0 (0) 46 (100) 
ADT-treated cases    
    Localized tumors 52 0 (0) 52 (100) 
Lethal metastatic cases (castration resistant)    
    Patients 32 24 (75) 8 (25) 
    Metastatic lesions 113 84 (74) 29 (26) 
    Primary tumors at autopsy 11 7 (64) 4 (36) 
    Preandrogen ablation tumor tissue* 0 (0) 4 (100) 
*

ADT-naive samples in men who later developed Nestin-positive castration-resistant metastases.

Close Modal

or Create an Account

Close Modal
Close Modal